Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

AstraZeneca reported $2.15B in EBIT for its fiscal quarter ending in September of 2023.

Ebit Change Date
AbbVie USD 2.41B 2.49B Sep/2023
Alcon AG USD 291M 20M Sep/2023
Almirall EUR 17.76M 8.92M Jun/2023
Amgen USD 2.05B 701M Sep/2023
Artemis Alpha GBP -16578000 10.12M Jun/2022
AstraZeneca USD 2.15B 418M Sep/2023
Bayer EUR 709M 825M Sep/2023
Biogen USD 285.3M 392.9M Sep/2023
Bristol-Myers Squibb USD 2.72B 194M Sep/2023
Eli Lilly USD 3.43B 1.2B Sep/2023
Galapagos EUR -30233000 19.54M Sep/2023
Genmab DKK 1.72B 220M Sep/2023
Gilead Sciences USD 2.62B 958M Sep/2023
GlaxoSmithKline GBP 2.59B 602M Sep/2023
GRIFOLS EUR 243.07M 12.7M Sep/2023
Haleon 682M 115M Sep/2023
Hikma Pharmaceutical USD 362M 109M Jun/2023
Lonza CHF 621M 280M Jun/2023
Merck EUR 1.04B 74M Sep/2023
Merck USD 6.52B 10.93B Sep/2023
Orion EUR 80M 33.5M Sep/2023
Pfizer USD -3149000000 5.27B Sep/2023
Philips EUR 386M 4M Sep/2023
Recordati EUR 153.44M 1.78M Sep/2023
Regeneron Pharmaceuticals USD 1.21B 194.5M Sep/2023
Roche Holding CHF 10.6B 2.12B Jun/2023
UCB EUR 341M 217M Jun/2023